Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2025-12-27 @ 2:33 AM
Study NCT ID:
NCT04951050
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-09
First Post:
2021-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment
Sponsor:
Shanghai MicroPort Medical (Group) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-26
First Submit QC Date:
None
Study First Post Date:
2021-07-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-08
Last Update Post Date:
2023-11-09
Last Update Post Date Type:
ACTUAL